These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

415 related items for PubMed ID: 20054821

  • 1. Expression of toll-like receptor-9 is increased in poorly differentiated prostate tumors.
    Väisänen MR, Väisänen T, Jukkola-Vuorinen A, Vuopala KS, Desmond R, Selander KS, Vaarala MH.
    Prostate; 2010 Jun 01; 70(8):817-24. PubMed ID: 20054821
    [Abstract] [Full Text] [Related]

  • 2. Expression of androgen and estrogen related proteins in normal weight and obese prostate cancer patients.
    Gross M, Ramirez C, Luthringer D, Nepomuceno E, Vollmer R, Burchette J, Freedland SJ.
    Prostate; 2009 Apr 01; 69(5):520-7. PubMed ID: 19107851
    [Abstract] [Full Text] [Related]

  • 3. Quantitative RT-PCR analysis of estrogen receptor gene expression in laser microdissected prostate cancer tissue.
    Walton TJ, Li G, McCulloch TA, Seth R, Powe DG, Bishop MC, Rees RC.
    Prostate; 2009 Jun 01; 69(8):810-9. PubMed ID: 19189301
    [Abstract] [Full Text] [Related]

  • 4. Expression of insulin-like growth factor-1 receptor in local and metastatic prostate cancer.
    Ryan CJ, Haqq CM, Simko J, Nonaka DF, Chan JM, Weinberg V, Small EJ, Goldfine ID.
    Urol Oncol; 2007 Jun 01; 25(2):134-40. PubMed ID: 17349528
    [Abstract] [Full Text] [Related]

  • 5. Expression of RAC 3, a steroid hormone receptor co-activator in prostate cancer.
    Gnanapragasam VJ, Leung HY, Pulimood AS, Neal DE, Robson CN.
    Br J Cancer; 2001 Dec 14; 85(12):1928-36. PubMed ID: 11747336
    [Abstract] [Full Text] [Related]

  • 6. Androgen receptor expression in prostatic intraepithelial neoplasia and cancer.
    Sweat SD, Pacelli A, Bergstralh EJ, Slezak JM, Bostwick DG.
    J Urol; 1999 Apr 14; 161(4):1229-32. PubMed ID: 10081875
    [Abstract] [Full Text] [Related]

  • 7. Differential expression of the estrogen receptor beta (ERbeta) in human prostate tissue, premalignant changes, and in primary, metastatic, and recurrent prostatic adenocarcinoma.
    Fixemer T, Remberger K, Bonkhoff H.
    Prostate; 2003 Feb 01; 54(2):79-87. PubMed ID: 12497580
    [Abstract] [Full Text] [Related]

  • 8. Expression of ERalpha and ERbeta in prostate cancer.
    Linja MJ, Savinainen KJ, Tammela TL, Isola JJ, Visakorpi T.
    Prostate; 2003 May 15; 55(3):180-6. PubMed ID: 12692783
    [Abstract] [Full Text] [Related]

  • 9. Expression of oestrogen receptor-alpha and oestrogen receptor-beta in prostate cancer.
    Yang GS, Wang Y, Wang P, Chen ZD.
    Chin Med J (Engl); 2007 Sep 20; 120(18):1611-5. PubMed ID: 17908481
    [Abstract] [Full Text] [Related]

  • 10. Altered expression of estrogen receptor alpha and beta in advanced gastric adenocarcinoma: correlation with prothymosin alpha and clinicopathological parameters.
    Wang M, Pan JY, Song GR, Chen HB, An LJ, Qu SX.
    Eur J Surg Oncol; 2007 Mar 20; 33(2):195-201. PubMed ID: 17046193
    [Abstract] [Full Text] [Related]

  • 11. Heat shock protein expression independently predicts clinical outcome in prostate cancer.
    Cornford PA, Dodson AR, Parsons KF, Desmond AD, Woolfenden A, Fordham M, Neoptolemos JP, Ke Y, Foster CS.
    Cancer Res; 2000 Dec 15; 60(24):7099-105. PubMed ID: 11156417
    [Abstract] [Full Text] [Related]

  • 12. Expression of the forkhead transcription factor FOXP1 is associated both with hypoxia inducible factors (HIFs) and the androgen receptor in prostate cancer but is not directly regulated by androgens or hypoxia.
    Banham AH, Boddy J, Launchbury R, Han C, Turley H, Malone PR, Harris AL, Fox SB.
    Prostate; 2007 Jul 01; 67(10):1091-8. PubMed ID: 17477366
    [Abstract] [Full Text] [Related]

  • 13. Androgen receptor expression in prostate cancer lymph node metastases is predictive of outcome after surgery.
    Sweat SD, Pacelli A, Bergstralh EJ, Slezak JM, Cheng L, Bostwick DG.
    J Urol; 1999 Apr 01; 161(4):1233-7. PubMed ID: 10081876
    [Abstract] [Full Text] [Related]

  • 14. Hormonal regulation of beta2-adrenergic receptor level in prostate cancer.
    Ramberg H, Eide T, Krobert KA, Levy FO, Dizeyi N, Bjartell AS, Abrahamsson PA, Taskén KA.
    Prostate; 2008 Jul 01; 68(10):1133-42. PubMed ID: 18454446
    [Abstract] [Full Text] [Related]

  • 15. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.
    Leav I, Schelling KH, Adams JY, Merk FB, Alroy J.
    Prostate; 2001 May 15; 47(3):149-63. PubMed ID: 11351344
    [Abstract] [Full Text] [Related]

  • 16. Toll like receptor-9 agonists stimulate prostate cancer invasion in vitro.
    Ilvesaro JM, Merrell MA, Swain TM, Davidson J, Zayzafoon M, Harris KW, Selander KS.
    Prostate; 2007 May 15; 67(7):774-81. PubMed ID: 17373717
    [Abstract] [Full Text] [Related]

  • 17. Expression of androgen receptor through androgen-converting enzymes is associated with biological aggressiveness in prostate cancer.
    Wako K, Kawasaki T, Yamana K, Suzuki K, Jiang S, Umezu H, Nishiyama T, Takahashi K, Hamakubo T, Kodama T, Naito M.
    J Clin Pathol; 2008 Apr 15; 61(4):448-54. PubMed ID: 17720776
    [Abstract] [Full Text] [Related]

  • 18. Frequent loss of estrogen receptor-beta expression in prostate cancer.
    Horvath LG, Henshall SM, Lee CS, Head DR, Quinn DI, Makela S, Delprado W, Golovsky D, Brenner PC, O'Neill G, Kooner R, Stricker PD, Grygiel JJ, Gustafsson JA, Sutherland RL.
    Cancer Res; 2001 Jul 15; 61(14):5331-5. PubMed ID: 11454669
    [Abstract] [Full Text] [Related]

  • 19. Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma.
    Leav I, Schelling KH, Adams JY, Merk FB, Alroy J.
    Prostate; 2001 Aug 01; 48(3):210-24. PubMed ID: 11494337
    [Abstract] [Full Text] [Related]

  • 20. Expression of RIZ1 protein (Retinoblastoma-interacting zinc-finger protein 1) in prostate cancer epithelial cells changes with cancer grade progression and is modulated in vitro by DHT and E2.
    Rossi V, Staibano S, Abbondanza C, Pasquali D, De Rosa C, Mascolo M, Bellastella G, Visconti D, De Bellis A, Moncharmont B, De Rosa G, Puca GA, Bellastella A, Sinisi AA.
    J Cell Physiol; 2009 Dec 01; 221(3):771-7. PubMed ID: 19746436
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.